glp-1 discovery receptor assay: drug in the metabolic field The Power of Discovery: GLP-1

[DOI] [PMC free article] [PubMed] [Google Scholar] 154

Those currently using a GLP-1 receptor agonist had a higher risk for thyroid cancer compared with those not currently using the medication (adjusted HR = 1.46

The meals that trigger the most GLP-1 production combine fiber, protein, healthy fat, and volume

Its use is commonly associated with oily stools, flatulence, fecal urgency, and incontinence

If there is an effect, a short term laxative effect or stomach discomfort is the most common and is completely normal easing within 24-72 hours

Dosing accuracy and compounded preparations The FDA's adverse event reporting data on compounded GLP-1 products includes numerous reports of dosing errors, including cases where patients received substantially higher doses than intended when self-administering from multi-dose vials